Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: Complementary role in the diagnosis of Parkinson's disease

2009 ◽  
Vol 15 (4) ◽  
pp. 270-272 ◽  
Author(s):  
Yoshinori Kajimoto ◽  
Hideto Miwa ◽  
Masae Okawa-Izawa ◽  
Masaya Hironishi ◽  
Tomoyoshi Kondo
2015 ◽  
Vol 21 (8) ◽  
pp. 923-928 ◽  
Author(s):  
Dun-hui Li ◽  
Lin-yuan Zhang ◽  
Yun-yun Hu ◽  
Xu-feng Jiang ◽  
Hai-yan Zhou ◽  
...  

2012 ◽  
Vol 10 (2) ◽  
pp. 242-246 ◽  
Author(s):  
Edson Bor-Seng-Shu ◽  
José Luiz Pedroso ◽  
Daniel Ciampi de Andrade ◽  
Orlando Graziani Povoas Barsottini ◽  
Luiz Augusto Franco de Andrade ◽  
...  

Transcranial sonography has become a useful tool in the differential diagnosis of parkinsonian syndromes. This is a non-invasive, low cost procedure. The main finding on transcranial sonography in patients with idiopathic Parkinson's disease is an increased echogenicity of the mesencephalic substantia nigra region. This hyperechogenicity is present in more than 90% of cases, and reflects a dysfunction in the dopaminergic nigrostriatal pathway. This study discussed how the hyperechogenicity of the substantia nigra may facilitate the differential diagnosis of parkinsonian syndromes.


2007 ◽  
Vol 254 (S4) ◽  
pp. IV15-IV20
Author(s):  
Hideto Miwa ◽  
Masae Okawa ◽  
Yoshinori Kajimoto ◽  
Tomoyoshi Kondo

2021 ◽  
Vol 2021 ◽  
pp. 1-9
Author(s):  
Yan-Liang Mei ◽  
Jing Yang ◽  
Zheng-Rong Wu ◽  
Ying Yang ◽  
Yu-Ming Xu

This meta-analysis aimed to evaluate the accuracy of hyperechogenicity of the substantia nigra (SN) for the differential diagnosis of Parkinson’s disease (PD) and other movement disorders. We systematically searched the PubMed, EMBASE, Cochrane Library, and China National Knowledge Infrastructure databases for relevant studies published between January 2015 and May 2020. Eligible articles comparing the echogenicity of the SN between patients with PD and those with other movement disorders were screened, and two independent reviewers extracted data according to the inclusion and exclusion criteria. Statistical analyses were conducted using STATA (version 15.0) (Stata Corporation, College Station, TX, USA), Review Manager 5.3 (Cochrane Collaboration), and Meta-DiSc1.4 to assess the pooled diagnostic value of transcranial sonography (TCS) for PD. Nine studies with a total of 1046 participants, including 669 patients with PD, were included in the final meta-analysis. Our meta-analysis demonstrated that hyperechogenicity of the SN had a pooled sensitivity and specificity of 0.85 (0.82, 0.87) and 0.71 (0.66, 0.75), respectively, for distinguishing idiopathic Parkinson’s disease from other movement disorders. Furthermore, the area under the curve of the summary receiver operating characteristic was 0.94. Transcranial sonography of the SN is a valuable tool for the differential diagnosis of PD and other movement disorders.


Sign in / Sign up

Export Citation Format

Share Document